Company Filing History:
1 out of 869 
1 out of 55 
1 out of 1,743 
Years Active: 1991
Title: The Innovations of Jean Montreuil in the Fight Against Bilharzioses
Introduction
Jean Montreuil, based in Villeneuve D'Ascq, France, is an esteemed inventor known for his significant contributions to medical research, particularly in the field of immunology. With a focused approach to tackling diseases, Montreuil has made strides in developing innovative solutions to combat bilateral infections.
Latest Patents
Montreuil holds one notable patent that showcases his inventive prowess. His patent, titled "Immunogenic Fraction Active Against Bilharzioses, Its Preparation," is focused on a glycoprotein extracted from the hemocyanin of a mollusc. This patent introduces an immunogenic fraction whose glucidic component constitutes 5 to 25% of the glycoprotein molecule, revealing a specific molar composition that plays a critical role in combating bilharzioses.
Career Highlights
Throughout his career, Montreuil has been affiliated with prominent research institutions, including the Institut Pasteur and the Institut Pasteur de Lille. His work in these establishments has reinforced his position as a leading figure in medical research, contributing to advancements in infectious disease management and vaccine development.
Collaborations
During his professional journey, Montreuil has had the opportunity to collaborate with notable colleagues such as Genevieve Spik and Andre Capron. These collaborations have enabled him to draw upon diverse expertise, further enriching his research output and leading to impactful innovations.
Conclusion
Jean Montreuil's dedication to advancing medical science is evident through his innovative patent addressing bilharzioses. His academic affiliations and collaborative efforts highlight the importance of teamwork in research, positioning him as a valuable inventor in the field of immunology.